Condition 1: Diabetes. Condition 2: Iron deficiency anemia. Diabetes mellitus due to underlying condition Iron deficiency anemia
Conditions
Interventions
Intervention group: Ferrous sulfate tablet, 325 mg, Rouzdarou pharmaceutical co, oral, daily, for 6 months.
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: More than one year has passed since the diagnosis of type 2 diabetes Age 30-50 years Iron deficiency anemia with hemoglobin less than 12
Exclusion criteria
Exclusion criteria: Insulin therapy Polymenorrhea Chronic diarrhea History of gastrectomy CRP above 10 mg/L Pregnancy Breast-feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance. Timepoint: Six months after beginning treatment. Method of measurement: HOMA-IR formula.;Hemoglobin A1C. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, High-performance liquid chromatography. | — |
Secondary
| Measure | Time frame |
|---|---|
| The level of blood triglycerides. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, Enzymatic photometric test.;The level of blood cholestrol. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, Enzymatic test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojtaba Tavasoli
Ghoum University of Medical Sciences
Outcome results
None listed